Velarion · Company Intelligence
CompBrief
Fiscal year 2025

Josh Mandel-Brehm — FY2025 total compensation $3,327,238

Josh Mandel-Brehm is President and Chief Executive Officer of Camp4 Therapeutics Corp (CAMP). The company reported total compensation of $3,327,238 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$600,000
Bonus$0
Stock awards$0
Option awards$2,430,988
Non-equity incentive plan$285,750
Pension and non-qualified deferred compensation$0
All other compensation$10,500
Total$3,327,238

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Camp4 Therapeutics Corp filed April 23, 2026, accession 0001736730-26-000026.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025President and Chief Executive Officer$600,000$0$0$2,430,988$285,750$0$10,500$3,327,238
FY2024Chief Executive Officer$557,250$404,991$201,000$1,131,744$2,294,985

Totals as disclosed in each year's own compensation disclosure for Camp4 Therapeutics Corp.

04

The other named executive officers of Camp4 Therapeutics Corp

Named executive officerRoleFY2025 total
Josh Mandel-Brehm this pagePresident and Chief Executive Officer$3,327,238
Kelly GoldChief Financial Officer$1,846,733
Yuri MaricichChief Medical Officer$1,814,042

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Camp4 Therapeutics Corp compensation brief.

05

The company page

Josh Mandel-Brehm's compensation sits inside Camp4 Therapeutics Corp's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Camp4 Therapeutics Corp (CAMP) compensation brief